Matches in Wikidata for { <http://www.wikidata.org/entity/Q71611891> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q71611891 description "article scientifique publié en 1996" @default.
- Q71611891 description "artículu científicu espublizáu en xunetu de 1996" @default.
- Q71611891 description "im Juli 1996 veröffentlichter wissenschaftlicher Artikel" @default.
- Q71611891 description "scientific article published on 01 July 1996" @default.
- Q71611891 description "wetenschappelijk artikel" @default.
- Q71611891 description "наукова стаття, опублікована в липні 1996" @default.
- Q71611891 name "Adjuvant cyclophosphamide, methotrexate and fluorouracil in node-negative and estrogen receptor-negative breast cancer. Updated results" @default.
- Q71611891 name "Adjuvant cyclophosphamide, methotrexate and fluorouracil in node-negative and estrogen receptor-negative breast cancer. Updated results" @default.
- Q71611891 type Item @default.
- Q71611891 label "Adjuvant cyclophosphamide, methotrexate and fluorouracil in node-negative and estrogen receptor-negative breast cancer. Updated results" @default.
- Q71611891 label "Adjuvant cyclophosphamide, methotrexate and fluorouracil in node-negative and estrogen receptor-negative breast cancer. Updated results" @default.
- Q71611891 prefLabel "Adjuvant cyclophosphamide, methotrexate and fluorouracil in node-negative and estrogen receptor-negative breast cancer. Updated results" @default.
- Q71611891 prefLabel "Adjuvant cyclophosphamide, methotrexate and fluorouracil in node-negative and estrogen receptor-negative breast cancer. Updated results" @default.
- Q71611891 P1433 Q71611891-4D7C977E-0A60-4AD2-B706-9F7D04F9D5A5 @default.
- Q71611891 P1476 Q71611891-20D1AA71-ECF0-4DF9-9F0C-A1FEAA47FD74 @default.
- Q71611891 P2093 Q71611891-113B5AE8-C459-4C76-978E-88B08E2FE3C8 @default.
- Q71611891 P2093 Q71611891-99BF572D-D9C0-4030-95C2-61B7EC1C64CC @default.
- Q71611891 P2093 Q71611891-F45AA3DB-7487-4D3A-823E-B646C8C04A0A @default.
- Q71611891 P304 Q71611891-2335ADC8-EF62-4FF1-89D6-6564C577DC8B @default.
- Q71611891 P31 Q71611891-BC851D4B-384F-447E-AD62-316FD276C65C @default.
- Q71611891 P356 Q71611891-A3826945-3983-4399-8585-D6FF28365237 @default.
- Q71611891 P433 Q71611891-B5B16CE9-E408-4266-896E-87E64436C644 @default.
- Q71611891 P478 Q71611891-12B836AD-95C5-4AB2-BBC9-F276C0812022 @default.
- Q71611891 P577 Q71611891-690FE381-6AE8-44A2-A0FC-DF0585061081 @default.
- Q71611891 P698 Q71611891-203225AA-E53C-43FE-8B93-215463BE4DB8 @default.
- Q71611891 P921 Q71611891-1F04D34A-B812-4352-9300-94AD1D01D287 @default.
- Q71611891 P921 Q71611891-2E5CDE12-A20B-4875-9E31-53E363041FB1 @default.
- Q71611891 P921 Q71611891-BBE135BD-0454-4F0E-BECD-E8670C354986 @default.
- Q71611891 P356 OXFORDJOURNALS.ANNONC.A010636 @default.
- Q71611891 P698 8839902 @default.
- Q71611891 P1433 Q326122 @default.
- Q71611891 P1476 "Adjuvant cyclophosphamide, methotrexate and fluorouracil in node-negative and estrogen receptor-negative breast cancer. Updated results" @default.
- Q71611891 P2093 "G Bonadonna" @default.
- Q71611891 P2093 "M Zambetti" @default.
- Q71611891 P2093 "P Valagussa" @default.
- Q71611891 P304 "481-485" @default.
- Q71611891 P31 Q13442814 @default.
- Q71611891 P356 "10.1093/OXFORDJOURNALS.ANNONC.A010636" @default.
- Q71611891 P433 "5" @default.
- Q71611891 P478 "7" @default.
- Q71611891 P577 "1996-07-01T00:00:00Z" @default.
- Q71611891 P698 "8839902" @default.
- Q71611891 P921 Q18553637 @default.
- Q71611891 P921 Q238512 @default.
- Q71611891 P921 Q422232 @default.